Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer

Clinical trial NCT00096265 · TERMINATED

Trial details

NCT number: NCT00096265
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Malignant Neoplasm in the Brain Recurrent Non-Small Cell Lung Carcinoma Stage IV Non-Small Cell Lung Cancer AJCC v7

Start date: 2004-10-06
Primary completion: 2011-06-14
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.